Inside the Diagnostics Industry: Software Tailors NGS Results for Maximum Clinical Utility

Software maker Syapse (Palo Alto, Calif.) is on a mission to bring best-in-practice software to the genomics industry. Syapse has developed a software platform that serves as a functional bridge … [Read more...]

New Guidelines, High-Cost Treatments Driving Surge in HCV Testing

Laboratories can expect to see a surge in hepatitis C virus (HCV)-related testing given adoption of expanded guidelines calling for one-time screening of all baby boomers, who are now more likely to … [Read more...]

Inside the Diagnostics Industry: Sequencing Continues Making Headlines, Though Panels Will Dominate in Short Term

Rapid incorporation of sequencing into clinical practice is stirring excitement in the molecular diagnostics industry, but in reality this method faces some hurdles. The emerging clinical applications … [Read more...]

G2 Index Up 9% in 2014, Surpassing Broader Market

The G2 Diagnostic Stock Index gained over 9 percent for the first half of the year (Jan. 2 to July 31). Ten stocks increased for the period, while five stocks lost ground. The G2 Diagnostic Stock … [Read more...]

Preemptive Pharmacogenomic Testing Can Be Successfully Implemented, Integrated Into Care

Pharmacogenomic (PGx) testing is at the epicenter of personalized medicine, with the promise that accessible genomic information will lead to more informed prescribing practices—enabling prescription … [Read more...]

G2 Insider: Outpatient Serum Folate Testing Unnecessary

Serum folate testing is significantly overused given the “exceedingly low” rates of detected serum folate deficiencies, according to a research letter published Aug. 11 in JAMA Internal Medicine. … [Read more...]

Laboratory Industry Split on Anticipated Impact of FDA’s LDT Regulation Framework

The laboratory industry has now had a few weeks to mull over the U.S. Food and Drug Administration’s (FDA’s) framework for increasing its regulation of laboratory-developed tests (LDTs), and the … [Read more...]

Special Focus: Rapid Pathogen Testing: Rapid Pathogen Testing Pushing Ahead on Two Fronts

Rapid pathogen testing (RPT) has evolved dramatically in the past decade with the routine clinical use of molecular-based technologies. The simultaneous migration toward fixed-cost reimbursement for … [Read more...]

Inside the Diagnostics Industry: Trovagene Looks to Transform Cancer Care Using Cell-Free DNA

Trovagene (San Diego) sees an opportunity to transform cancer care through noninvasive genomic monitoring using cell-free DNA. Unlike other technologies that rely upon blood samples, Trovagene’s … [Read more...]

Lawrence Livermore Supersizes the Microarray

Developers assess many considerations when making the determination of the size of a multiplex panel: comprehensiveness versus actionability, efficiency versus sensitivity. While targeted, moderately … [Read more...]